3044永利官网vip(官方VIP认证)-最新版App Store

Runke Bioengineering's DHA R&D Project Approved by Fujian Science and Technology Department
DateTime:2021-09-08  

On September 8, 2021, the research and development project "High-Content DHA Research and Development Project" of Runke Bioengineering (Fujian) Co., Ltd. has received approval and support from the 2020 Provincial Science and Technology Plan Project of Fujian Provincial Science and Technology Department.

Through the implementation of this project, DHA ethyl ester and DHA triglycerides can be obtained, extending the industrial chain of DHA and high-content DHA production from marine microalgae. This not only improves resource utilization efficiency but also promotes energy conservation, emission reduction, and industrial structural upgrading for related enterprises. At the same time, it breaks the monopoly of foreign enterprises in the high-content DHA product market in China, promoting the application and development of high-content DHA in the fields of pharmaceuticals, health care products, additive industries, etc. This effectively drives technological progress in the industry, resulting in remarkable economic and social benefits.